US Patent Issued to Regeneron Pharmaceuticals on Feb. 25 for "Eukaryotic cells comprising adenovirus-associated virus polynucleotides" (New York Inventors)

ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,234,472, issued on Feb. 25, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Eukaryotic cells comprising adenovirus-associated virus polynucleotides" was invented by Michael Goren (Tarrytown, N.Y.), Yu Zhao (Willison Park, N.Y.), Alexandros Strikoudis (New York), Darya Burakov (Tarrytown, N.Y.) and Gang Chen (Yorktown Heights, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present inventions provide eukaryotic cells, such as mammalian cells, that comprise adeno-associated virus (AAV) polynucleotides, including AAV capsid proteins (Cap), and are capable of expressing the polypeptides encoded by the AAV polynucleotides, and ther...